Caris Life Sciences Shares Climb After $494 Million IPO

Caris Life Sciences Inc. jumped 33% after the health-care company raised $494 million in a US initial public offering that priced above the top of its marketed range.

Shares of the Sixth Street Partners-backed firm, which uses technology to help diagnose and treat cancer, closed at $28 each on Wednesday in New York, versus an IPO price of $21 apiece. Caris sold 23.5 million shares in the IPO after offering them for $19 to $20 each, in a range that had already been increased.